init innovation in traffic systems (IXX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
13 May, 2026Executive summary
Achieved record Q1 2026 revenue of €98.2m, up 39.5% year-over-year, driven by major North American projects, especially MARTA and Houston, despite global economic shocks.
EBIT rose to €6.7m from €2.0m in Q1 2025, reflecting economies of scale and cost measures, with net profit reaching €4.1m.
Order intake for Q1 2026 was €76.7m, slightly above prior year, while order backlog declined to €313m due to strong backlog conversion.
FY 2026 targets confirmed, with major projects, restructuring, and new management structure underway.
Secured landmark contract for Sydney's Opal+ ticketing system, valued at approx. AUD 615m (EUR 376m), with installation by 2028 and a ten-year operation phase.
Financial highlights
Revenue increased to €98.2m from €70.4m in Q1 2025, a 39.5% year-over-year rise.
EBIT margin improved to 6.8% from 2.8% year-over-year.
Gross profit reached €30.9m, though gross margin fell to 31% from 33% due to project scope changes.
Operating cash flow declined to €3.4m from €15.5m due to prior year pre-payments and lower working capital contributions.
Net capex reduced following completion of nextGen investments.
Outlook and guidance
FY 2026 revenue forecast at €380–410m, EBIT at €38–42m, and cash flow at €32–42m.
Segment revenue and EBIT guidance: Integrated Systems (€280–300m, €34–36m), Cloud Solutions (€40–45m, €5–7m), Passenger Intelligence (€90–100m, €7–9m).
EBIT margin above 10% targeted for 2026.
Recent Sydney contract win confirms global positioning but is not expected to impact 2026 targets.
Management sees no current supply or demand disruptions and expects to meet growth targets.
Latest events from init innovation in traffic systems
- Revenue up 24% to €330m, EBIT margin 9.9%, strong outlook for 2026.IXX
Q4 202519 Mar 2026 - Q3 2025 delivered robust growth and confirmed outlook, amid rising global trade uncertainty.IXX
Q3 202513 Nov 2025 - Strong revenue and profit growth in H1 2024, fueled by major international contracts.IXX
Q2 202420 Aug 2025 - Record revenue and order intake, with major project wins and strong growth outlook.IXX
Q4 202420 Aug 2025 - Strong order growth, DILAX acquisition, and robust outlook drive continued expansion.IXX
Q3 202420 Aug 2025 - Revenue up 39.5% to €70.4m, but EBIT and net profit fell; guidance reaffirmed.IXX
Q1 202520 Aug 2025 - Revenue up 24% in H1 2025; guidance raised after major US project win and strong cash flow.IXX
Q2 202520 Aug 2025